TB risk during treatment with biological agents and Janus kinase inhibitors: an umbrella review. Alves RF, Hilario C, Ferreira NB, Cascais M, et al. Int J Tuberc Lung Dis 2026;30:244-254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alves RF, Hilario C, Ferreira NB, Cascais M, et al. TB risk during treatment with biological agents and Janus kinase inhibitors: an umbrella review. Int J Tuberc Lung Dis 2026;30:244-254.
PMID: 42226371